139
Views
0
CrossRef citations to date
0
Altmetric
Research Article

The construction of gold hybrid supramolecular hydrogels for doxorubicin delivery

& ORCID Icon
Pages 202-210 | Received 14 Jun 2021, Accepted 19 Aug 2021, Published online: 08 Sep 2021

References

  • Ostrom QT, Gittleman H, Farach P, et al. CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2006–2010. Neuro Oncol. 2013;15:ii1–56.
  • Wen PY, Kesari SN. Malignant gliomas in adults. Engl J Med. 2008;359:492–507.
  • Hu Y, Liu Y, Xie X, et al. Surfactant-regulated fabrication of gold nanostars in magnetic core/shell hybrid nanoparticles for controlled release of drug. J Colloid Interf Sci. 2018;529:547–555.
  • Jafarzadeh-Holagh S, Hashemi-Najafabadi S, Shaki H, et al. Self-assembled and pH-sensitive mixed micelles as an intracellular doxorubicin delivery system. J Colloid Interf Sci. 2018;523:179–190.
  • Lim JYC, Lin Q, Xue K, et al. Recent advances in supramolecular hydrogels for biomedical applications. Mater Today Adv. 2019;3:100021.
  • Zhang Z, He Z, Liang R, et al. Fabrication of a micellar supramolecular hydrogel for ocular drug delivery. Biomacromolecules. 2016;17:798–807.
  • Li F, Yang H, Bie N, et al. Zwitterionic temperature/redox-sensitive nanogels for near-infrared light-triggered synergistic thermo-chemotherapy. ACS Appl Mater Interfaces. 2017;9:23564–23573.
  • Wenz G, Han BH, Muller A. Chem Rev. 2006;106:782–817.
  • Zelenka J, Koncošová M, Ruml T. Biotechnol Adv. 2018;36:583–602.
  • Zhou Y, Ding BZ, Lin YP, et al. MiR-34a, as a suppressor, enhance the susceptibility of gastric cancer cell to luteolin by directly targeting HK1. Gene. 2018;644:56–65.
  • Peng B, Zi J, Yan W. Measurement and correlation of solubilities of luteolin in organic solvents at different temperatures. J Chem Eng Data. 2006;51:2038–2040.
  • Qing W, Wang Y, Li H, et al. Preparation and characterization of copolymer micelles for the solubilization and in vitro release of luteolin and luteoloside. AAPS PharmSciTech. 2017;18:2095–2101.
  • Qing W, Wang Y, Li H, et al. Hydrogels generated by low-molecular-weight PEGylated luteolin and α-cyclodextrin through self-assembly for 5-fluorouracil delivery. RSC Adv. 2016;6:95812–95817.
  • Shukla R, Bansal V, Chaudhary M, et al. Biocompatibility of gold nanoparticles and their endocytotic fate inside the cellular compartment: a microscopic overview. Langmuir. 2005;21:10644–10654.
  • Alkilany AM, Murphy CJ. Toxicity and cellular uptake of gold nanoparticles: what we have learned so far? Nanopart Res. 2010;12:2313–2333.
  • Franzoi AC, Vieira IC, Dupont J, et al. Biosensor for luteolin based on silver or gold nanoparticles in ionic liquid and laccase immobilized in chitosan modified with cyanuric chloride. Analyst. 2009;134:2320–2328.
  • Pu S, Sun H, Hou X, et al. A colorimetric assay for the determination of trace arsenic based on in-situ formation of AuNPs with synergistic effect of arsine and iodide. Anal Chim Acta. 2021;1144:61–67.
  • Yoosaf K, Ipe BI, Suresh CH, et al. In situ synthesis of metal nanoparticles and selective naked-eye detection of lead ions from aqueous media. J Phys Chem C. 2007;111:12839–12847.
  • Heutz NA, Dolcet P, Birkner A, et al. Inorganic chemistry in a nanoreactor: au/TiO2 nanocomposites by photolysis of a single-source precursor in miniemulsion. Nanoscale. 2013;5:10534–10541.
  • Sobczak-Kupiec A, Tyliszczak B, Krupa-Zuczek K, et al. Gold nanoparticles as a modifying agent of ceramic-polymer composites. Arch Metall Mater. 2014;59:1005–1009.
  • Harada A, Li J, Kamachi M. Double-stranded inclusion complexes of cyclodextrin threaded on poly(ethylene glycol). Nature. 1994;370:126–128.
  • Harada A. Cyclodextrin-based molecular machines. Acc Chem Res. 2001;34:456–464.
  • Bernhard S, Tibbitt MW. Supramolecular engineering of hydrogels for drug delivery. Adv Drug Deliver Rev. 2021;171:240–256.
  • Veiseh O, Kievit FM, Ellenbogen RG, et al. Cancer cell invasion: treatment and monitoring opportunities in nanomedicine. Adv Drug Deliver Rev. 2011;63:582–596.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.